BPC-157 is not FDA-approved for any therapeutic use
In regards to loss of weight, there is no documented outcome that supports vitamin B12 shots or injections promoting weight loss
intramuscular administration Subcutaneous (into fatty tissue of abdomen, typically 1-2 inches lateral to navel, using a 25-27 gauge, 5/8-inch needle): 28% report injection-site soreness Easier for self-administration Slower absorption (peak serum B12 at 12-18 hours vs
The peptide seems to impact nitric oxide pathways, which regulate vessel tone and tissue oxygenation, critical for a properly perfused endometrium during the implantation window
Research demonstrates benefits in the gastrointestinal system, musculoskeletal tissues, cardiovascular system, and nervous system
Quick Takeaways BPC-157 is a mechanistically compelling peptide with strong animal data on healing, inflammation, and neuroprotection Both injectable and oral forms of BPC_157 have well-established real-world utility, and are the only proven paths for experiencing the real healing benefits of BPC-157 Nasal spray bioavailability for BPC-157 is poor, a consistent observation of experienced clinicians and self-experimenters No human clinical trials exist for BPC-157 in any delivery format, including the nasal spray Intranasal delivery is theoretically interesting for CNS access, but specifically remains unvalidated when it comes to BPC-157 What Is BPC-157